Cargando…

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment

Evidence of tumor-resident mature B cell and antibody compartments and reports of associations with favorable prognosis in malignant melanoma suggest that humoral immunity could participate in antitumor defense. Likely striving to confer immunological protection while being subjected to tumor-promot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiaruttini, Giulia, Mele, Silvia, Opzoomer, James, Crescioli, Silvia, Ilieva, Kristina M., Lacy, Katie E., Karagiannis, Sophia N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414880/ https://www.ncbi.nlm.nih.gov/pubmed/28507802 http://dx.doi.org/10.1080/2162402X.2017.1294296

Ejemplares similares

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
por: Ilieva, Kristina M., et al.
Publicado: (2018)

Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology
por: Crescioli, Silvia, et al.
Publicado: (2018)

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
por: Pellizzari, Giulia, et al.
Publicado: (2019)

BRAF inhibitors: resistance and the promise of combination treatments for melanoma
por: Griffin, Merope, et al.
Publicado: (2017)

In Planta Glycan Engineering and Functional Activities of IgE Antibodies
por: Montero-Morales, Laura, et al.
Publicado: (2019)

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
por: Correa, Isabel, et al.
Publicado: (2018)

A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
por: Hoffmann, Ricarda M., et al.
Publicado: (2020)

Enriched circulating and tumor-resident TGF-β(+) regulatory B cells in patients with melanoma promote FOXP3(+) Tregs
por: Harris, Robert J, et al.
Publicado: (2022)

Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
por: Adams, Rebecca, et al.
Publicado: (2021)

Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review)
por: MALAS, SADEK, et al.
Publicado: (2014)

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
por: Pellizzari, Giulia, et al.
Publicado: (2021)

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
por: Chauhan, Jitesh, et al.
Publicado: (2023)

Interstitial fluid: the overlooked component of the tumor microenvironment?
por: Wiig, Helge, et al.
Publicado: (2010)

IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
por: Saul, Louise, et al.
Publicado: (2016)

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model
por: Williams, Iwan P., et al.
Publicado: (2019)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2017)

Pericytes, an overlooked player in vascular pathobiology
por: Ferland-McCollough, David, et al.
Publicado: (2017)

Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment
por: Georgouli, Mirella, et al.
Publicado: (2019)

Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients
por: Karagiannis, Panagiotis, et al.
Publicado: (2021)

Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma
por: Karagiannis, Panagiotis, et al.
Publicado: (2015)

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
por: Adams, Rebecca, et al.
Publicado: (2022)

Targeting folate receptor alpha for cancer treatment
por: Cheung, Anthony, et al.
Publicado: (2016)

Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
por: Khair, Duaa O., et al.
Publicado: (2019)

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
por: Willsmore, Zena N., et al.
Publicado: (2021)

In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
por: Man, Francis, et al.
Publicado: (2021)

NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma
por: Garofalo, Cinzia, et al.
Publicado: (2021)

AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody
por: Ilieva, Kristina M., et al.
Publicado: (2019)

Special Issue “Antibody Engineering for Cancer Immunotherapy”
por: Crescioli, Silvia, et al.
Publicado: (2022)

Evaluating Biomarkers in Melanoma
por: Karagiannis, Panagiotis, et al.
Publicado: (2015)

Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment
por: Ganguly, Debolina, et al.
Publicado: (2020)

Ceramide Transfer Protein (CERT): An Overlooked Molecular Player in Cancer
por: Chung, Long Hoa, et al.
Publicado: (2021)

MSCs interaction with the host lung microenvironment: An overlooked aspect?
por: Weiss, Daniel J., et al.
Publicado: (2022)

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields
por: Ilieva, Kristina M., et al.
Publicado: (2017)

Utilizing Immunocytokines for Cancer Therapy
por: Runbeck, Erin, et al.
Publicado: (2021)

Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies
por: Gilbert, Amy E., et al.
Publicado: (2011)

Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
por: Chanmee, Theerawut, et al.
Publicado: (2014)

Tumor-associated macrophages: an effective player of the tumor microenvironment
por: Basak, Udit, et al.
Publicado: (2023)

The Tumor Microenvironment: A Pitch for Multiple Players
por: Schiavoni, Giovanna, et al.
Publicado: (2013)

Interleukin-35 as an Emerging Player in Tumor Microenvironment
por: Xue, Wenhua, et al.
Publicado: (2019)

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
por: Crescioli, Silvia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d1n3udk26dicdrsc6odr3042ep